1. bookVolumen 32 (2019): Heft 1 (March 2019)
Zeitschriftendaten
License
Format
Zeitschrift
eISSN
2300-6676
ISSN
2084-980X
Erstveröffentlichung
30 May 2014
Erscheinungsweise
4 Hefte pro Jahr
Sprachen
Englisch
Uneingeschränkter Zugang

Increasing efficacy of treatment in patients with steatohepatitis and concomitant chronic colitis

Online veröffentlicht: 06 Apr 2019
Volumen & Heft: Volumen 32 (2019) - Heft 1 (March 2019)
Seitenbereich: 23 - 26
Eingereicht: 20 Dec 2017
Akzeptiert: 26 Apr 2018
Zeitschriftendaten
License
Format
Zeitschrift
eISSN
2300-6676
ISSN
2084-980X
Erstveröffentlichung
30 May 2014
Erscheinungsweise
4 Hefte pro Jahr
Sprachen
Englisch

1. Abenavoli L, Falalyeyeva T, Boccuto L, Tsyryuk O, Kobyliak N. Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease. Pharmaceuticals. 2018;11(104):10.10.3390/ph11040104631596530314377Search in Google Scholar

2. Machado MV, Cortez-Pinto H. Non-alcoholic fatty liver disease: what the clinician needs to know. World J Gastroenterol. 2014; 20:12956-80.10.3748/wjg.v20.i36.12956417747625278691Search in Google Scholar

3. Manzhalii E, Virchenko O, Falalyeyeva T, Beregova T, Stremmel W. Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: A pilot trial. J Dig Dis. 2017;18(12):698-703.10.1111/1751-2980.1256129148175Search in Google Scholar

4. Neuman MG, French SW, French BA, Seitz HK, Cohen LB, Mueller S, et al. Alcoholic and non-alcoholic steatohepatitis. Exp Mol Pathol. 2014;97(3):492-510.10.1016/j.yexmp.2014.09.005469606825217800Search in Google Scholar

5. Kondro M, Mykhalchyshyn G, Bodnar P, Kobyliak N, Falalyeyeva T. Metabolic profile and morpho-functional state of the liver in rats with glutamate-induced obesity. Curr Issues Pharm. Med. Sci. 2013;2(4):379-81.Search in Google Scholar

6. Drapkina OM, Korneeva OH, Ivashkin VT. [Treatment of nonalcoholic steatohepatitis in metabolic syndrome: focus on the essential phospholipids]. Lechaschiy Vrach. 2010;2:43-5.Search in Google Scholar

7. Gerok V, Blum KhE. [Liver and biliary system]. M.: MEDpressinform; 2009:199.Search in Google Scholar

8. Bataller R, Gao B. Liver fibrosis in alcoholic liver disease. Semin Liver Dis. 2015;35:146-56.10.1055/s-0035-155005425974900Search in Google Scholar

9. Weiler S, Merz M, Kullak-Ublick GA. Drug-induced liver injury: the dawn of biomarkers? F1000 Prime Rep. 2015;7:34.Search in Google Scholar

10. Polunina TE, Maev IV. [Nonalcoholic fatty liver disease: epidemiology, pathogenesis, diagnosis, treatment]. Gastroenterologiya. 2012;1. Article in RussianSearch in Google Scholar

11. Voieikova DO, Kondro MM, Falaleyeva TM, Ostapchenko LI. Activity of enzymes of mitochondrial electron transport chain of rat hepatocytes under different steatosis. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2016;7(4):752-5.Search in Google Scholar

12. Kondro M., Kobyliak N, Virchenko O, Falalyeyeva T, Beregova T, Bodnar P. Multiprobiotic therapy from childhood prevents the development of nonalcoholic fatty liver disease in adult monosodium glutamate-induced obese rats. Curr Issues Pharm. Med. Sci. 2014;2(4):243-5.Search in Google Scholar

13. Baykova IE, Nikitin IG. [Drug liver]. Ross. Med. Zhurn. 2009;1. Article in RussianSearch in Google Scholar

14. Buyeverov AO, Yeshanu VS, Mayevskaya MV, Ivashkin VT. [Application of essential phospholipids in complex therapy of steatohepatitis of the mixed origin]. Klin. Persp. Gastroenterol. Hepatol. 2008;1:17-22. Article in RussianSearch in Google Scholar

15. Weismuller TJ, Lankisch TO. [Biliary diseases – new insights and developments]. Dtsch. Med. Wochenschr. 2011;136:713.Search in Google Scholar

16. Kompanets I, Korotkiy A, Karpovets T, Ostapchenko L, Pilipenko S, Yankovskiy D. The interferon production and 2’,5’-oligoadenylatesynthetase activity in rat spleen lymphocytes at hypoacidity evoked by omeprazole injection and at administration of multiprobiotic «SYMBITER®». Curr Issues Pharm. Med. Sci. 2013;2(4):398-400.Search in Google Scholar

17. Korotkyi O, Vovk A, Blokhina O, Dvorshchenko K, Falalyeyeva T, Abenavoli L et al. Effect of Chondroitin Sulfate on blood serum cytokine profile during Carrageenan-induced edema and Monoiodoacetate-induced osteoarthritis in rats. Rev Recent Clin Trials. 2018;2.10.2174/157488711366618110211124730387401Search in Google Scholar

18. Khomeriki SG, Khomeriki NM. [Alcoholic liver disease: pathogenesis, morphological manifestations, differential diagnosis and pathogenetic approaches to therapy]. Gastroenterologiya. 2012;1. Article in RussianSearch in Google Scholar

19. Velkov VV. [Non-invasive biomarkers of fibrosis. Good-bye, biopsy?] Kliniko-laboratornyy consilium. 2009:30.Search in Google Scholar

Empfohlene Artikel von Trend MD

Planen Sie Ihre Fernkonferenz mit Scienceendo